Anaptysbio (ANAB) Operating Leases (2021 - 2026)
Anaptysbio's Operating Leases came in at $11.49 million for Q1 2026, down 15.6% from $13.61 million a year earlier and down 4.5% from the prior quarter.
Powered by 
Analysis
Anaptysbio (ANAB) Operating Leases (2021 - 2026) Analysis & Trends
At the end of FY2025, Anaptysbio's Operating Leases was $12.03 million, down 14.7% from FY2024.
- Operating Leases has declined in each of the last four years, with a four-year compound annual growth rate of -11.3% (FY2021 to FY2025).
- Going back by year, Operating Leases was $14.11 million in FY2024 (-12.0%), $16.04 million in FY2023 (-10.0%), $17.81 million in FY2022 (-8.4%) and $19.45 million in FY2021.
- The Q1 2026 figure represents the lowest quarterly Operating Leases in data going back to Q2 2021.
- Year-over-year, Operating Leases has declined for 16 consecutive quarters, with an average decline of 13.1% over the last eight quarters.
- Over the past five years, the year-over-year decline in Operating Leases ranged from 7.8% (Q2 2022) to 15.6% (Q1 2026).
- Business Quant data shows ANAB's Operating Leases at $12.03 million (Q4 2025), $12.57 million (Q3 2025) and $13.1 million (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Anaptysbio | 1.47 Bn | 362.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 11.49 Mn |
| Dec 31, 2025 | 12.03 Mn |
| Sep 30, 2025 | 12.57 Mn |
| Jun 30, 2025 | 13.10 Mn |
| Mar 31, 2025 | 13.61 Mn |
| Dec 31, 2024 | 14.11 Mn |
| Sep 30, 2024 | 14.61 Mn |
| Jun 30, 2024 | 15.10 Mn |
| Mar 31, 2024 | 15.58 Mn |
| Dec 31, 2023 | 16.04 Mn |
| Sep 30, 2023 | 16.49 Mn |
| Jun 30, 2023 | 16.95 Mn |
| Mar 31, 2023 | 17.39 Mn |
| Dec 31, 2022 | 17.81 Mn |
| Sep 30, 2022 | 18.24 Mn |
| Jun 30, 2022 | 18.65 Mn |
| Mar 31, 2022 | 19.06 Mn |
| Dec 31, 2021 | 19.45 Mn |
| Sep 30, 2021 | 19.84 Mn |
| Jun 30, 2021 | 20.22 Mn |
API Access
Anaptysbio Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=ANAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "ANAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=ANAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();